Lv2
120 积分 2020-08-14 加入
The causes and consequences of cancer-associated malnutrition
14小时前
待确认
Ivonescimab in advanced NSCLC: is progression-free survival enough, or are overall survival data also needed?
24天前
已完结
Ivonescimab: First Approval
24天前
已完结
Patterns of Failure, Low-Volume Relapse, and Subsequent Ablative Management in Locally Advanced Non-Small Cell Lung Cancer Treated With Definitive Chemoradiation and Consolidation Immune Checkpoint Inhibitors
1个月前
已完结
Patterns of Disease Progression with Durvalumab in Stage III Non-small Cell Lung Cancer (PACIFIC)
1个月前
已完结
HELPER study: A phase II trial of continuous infusion of endostar combined with concurrent etoposide plus cisplatin and radiotherapy for treatment of unresectable stage III non-small-cell lung cancer
1个月前
已完结
Stereotactic Radiation for the Comprehensive Treatment of Oligometastases (SABR-COMET): Extended Long-Term Outcomes
1个月前
已完结
The PI3K/AKT Pathway as a Target for Cancer Treatment
2个月前
已完结
Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway
2个月前
已完结
Targeting PI3K/AKT/mTOR pathway in non small cell lung cancer
2个月前
已完结
皖公网安备34019202002308
